Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
April 28, 2011
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
Quest's Focus Diagnostics gets CE Mark for Simplexa EBV and BK virus tests; Cepheid gets FDA nod for Xpert Flu test.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument
August 26, 2010 / PCR Insider - Quest's Focus Diagnostics Launches Nucleic Acid Extraction-Free Flu/RSV Test in Europe
November 3, 2011 / PCR Insider - PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen
March 14, 2013 / PCR Insider - Dx Focus: Focus Diagnostics' Simplexa Flu A/B & RSV Test
October 11, 2012 / PCR Insider - Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil
December 8, 2011 / PCR Insider